Algo version: 0.98b
Piramal Pharma Limited is listed at the NSE Exchange
Piramal Pharma Limited [PPLPHARMA.NS]
NSE Sector: Healthcare Industry:Biotechnology

Is Piramal Pharma Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Piramal Pharma Limited pays dividends. Last time was Sunday 25th of August 2024 where the investors holding the stock on Friday 12th of July 2024 were paid INR0.11 per share. Over the last 1 times between 2024 and 2024, Piramal Pharma Limited has paid INR0.11 with an average of INR0.11 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Piramal Pharma Limited 10 years ago, but if you had invested on Wednesday 19th of October 2022 when the price was INR185.56, you would have made a profit of INR40.75 per share or 21.96%

Yes, the average daily trading liquidity for Piramal Pharma Limited is INR5.99 million. You should therefore be able to get in and out of your positions relatively fast.

Piramal Pharma Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.24, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 0.22%, which is challenging.

We have calculated the inflation risk for Piramal Pharma Limited to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.